Two Days Left! ATS 2022 On-Demand
Learn more about the scientific sessions, industry presentations, and e-posters available now, and join us! The ATS 2022 On-Demand platform is open through June 24!
Upcoming Events
Annual Aging Interest Group Meeting
When: 1 p.m. ET, today, June 22, 2022
Register now!
Industry Innovations, “Integrating the Envisia Genomic Classifier to Improve ILD Diagnostic & Prognostic Confidence”
This session will discuss key considerations for the diagnosis of patients with Interstitial Lung Disease and provide a review on how to incorporate the Envisia Genomic Classifier as part of your ILD workup for a more confident diagnosis and prognosis.
When: 6:30 p.m. ET, today, June 22, 2022
Register now!
Sponsored by Veracyte.
Aging in Critical Care and Clinical Pulmonary Subgroups - Combined Business Meeting
When: 12 p.m. ET, June 23, 2022
Register now!
Telerehabilitation for Chronic Respiratory Disease: A Randomized Controlled Equivalence Trial
When: 5 p.m. ET, June 28, 2022
Register now!
Receive the ATSF Mark of Distinction
The ATS Fellow designation (ATSF) is a mark of distinction that recognizes the accomplishments, dedication, and contributions of ATS members to the Society and the fields of pulmonary, critical care, and sleep medicine.
ATSF applications are available for individuals who have been an ATS member for five or more of the past 10 years.
We will spotlight ATS Fellows on the ATS website, in member publications, and at the ATS International Conference. Fellows will also receive a certificate.
Deadline: Aug. 31, 2022
Help Develop CME eLearning Activities
ATS is developing a library of engaging eLearning activities for practicing clinicians and needs your help preparing appropriate content!
You can participate by helping us to:
- Repurpose existing content.
- Inventory content.
- Develop new content.
Have an idea to repurpose existing content or develop new content? Fill out this form!
Please contact Ernie Brown, senior eLearning Program Manager with any questions.
Available Now: New ATS ILD Primer
The fourth ATS ILD Primer, Hypersensitivity Pneumonia, is available now! This was a joint collaboration between the ATS and Boehringer Ingelheim Pharmaceuticals, Inc.
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
